Kenya BioVax Institute
-
Kenya signs landmark IVI agreement to host the Africa vaccine research hub in Nairobi
Under the partnership, IVI will collaborate closely with institutions such as the Kenya Medical Research Institute, the Kenya BioVax Institute, and the Pharmacy and Poisons Board to support vaccine development, manufacturing, and regulatory strengthening.
-
Kenya unveils major push for local vaccine manufacturing as French Minister visits BioVax Institute
The next phase will focus on installing and validating fill-and-finish equipment, strengthening quality control systems, building specialized workforce capacity, and preparing for compliant vaccine manufacturing.
-
Inteleos Foundation launches 2026 MedMissions Award in five African countries to improve maternal healthcare access
Each nonprofit will deploy targeted interventions designed to expand point-of-care ultrasound training, strengthen referral networks, and improve outcomes for high-risk pregnancies in resource-limited settings.
-
Kenya to triple science funding by 2036 as the KEMRI’s 16th KASH Conference begins in Nairobi
The conference has attracted significant participation, with 405 scientific abstracts submitted and 22 symposiums scheduled throughout the week.
-
Kenya accelerates local vaccine production with 2027 target as CS Duale visits Kenya BioVax Institute
The government has fully funded the first phase of the vaccine manufacturing facility, which has already reached completion.
-
Kenya BioVax Institute welcomes Dr. Wesley Ronoh as substantive CEO, succeeding Dr. Cecilia Wanjala
The handover ceremony took place at the Kenya BioVax headquarters and was presided over by Dr. Charles Githinji, the Chairman of the Board of Directors.